-
Mashup Score: 1
DENVER — Patients with inflammatory bowel disease and non-ST elevation myocardial infarction had higher mortality, hospital stays and hospital charges than patients with IBD alone, noted a presenter at the Crohn’s and Colitis Congress.“Based on our study results, IBD patients with non-STEMI require closer monitoring, and there needs to be a focus on better treatment and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 1VIDEO: Point-of-care, drug-level assays help predict ‘best time, best dose’ in IBD therapy - 1 year(s) ago
DENVER — In a Healio video exclusive, Alan Moss, MD, discusses his presentation at the Crohn’s and Colitis Congress, which detailed the use of therapeutic drug monitoring in the management of patients with inflammatory bowel disease. Speaking to attendees, Moss, director of the Crohn’s & Colitis program at Boston Medical Center, focused on three areas: the rationale and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#VIDEO with @moss_md: Point-of-care, #drug-level assays help predict ‘best time, best dose’ in #IBD therapy #CCCongress23 #GITwitter https://t.co/ayf14sbWUe
-
-
Mashup Score: 0Laura Wingate: Improving All Aspects of Care for IBD Patients - 1 year(s) ago
The FDA has approved several biologics in recent years for the treatment of patients with inflammatory bowel disease.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Laura Wingate of the @CrohnsColitisFn talks about current gaps in #IBD care during #CCCongress23. https://t.co/ltPGTgq4ex
-
-
Mashup Score: 1‘Evidence supports’ de-escalating combination therapy in patients with IBD after 1 year - 1 year(s) ago
DENVER — Providers should consider de-escalating combination therapy with immunomodulators to monotherapy after 1 year in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress. “We know that combination therapy is one of our most, if not the most, effective therapies: not the combination of biologics, but the combination of the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #CCCongress23: “#Evidence supports de-escalating combo therapy to stopping #immunomodulators,” @ryanungaro said. #GITwitter #MedTwitter #IBD https://t.co/u4JVxjcwzW
-
-
Mashup Score: 4Patients with IBD, ‘higher social vulnerability’ inadequately screened for mental health - 1 year(s) ago
DENVER — Depression was associated with higher social vulnerability in individuals with inflammatory bowel disease and was largely influenced by socioeconomic and minority status, according to data at the Crohn’s and Colitis Congress. “Similar to their chronic disease counterparts, patients with IBD have higher rates of anxiety and depression than the general population,”
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Depression was associated with higher social vulnerability in individuals with #IBD and was largely influenced by #socioeconomic and #minority status, @ariel_jordan22 presented at #CCCongress23 #GITwitter #MedTwitter https://t.co/OfH5it5GSy
-
-
Mashup Score: 1
DENVER — Patients with inflammatory bowel disease and non-ST elevation myocardial infarction had higher mortality, hospital stays and hospital charges than patients with IBD alone, noted a presenter at the Crohn’s and Colitis Congress.“Based on our study results, IBD patients with non-STEMI require closer monitoring, and there needs to be a focus on better treatment and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Patients with #IBD and non-ST elevation myocardial infarction had higher mortality, hospital stays and hospital charges than patients with IBD alone, @NeethiDasu noted at #CCCongress23. #GITwitter #MedTwitter https://t.co/PdldXWncZn
-
-
Mashup Score: 0VIDEO: Point-of-care, drug-level assays help predict ‘best time, best dose’ in IBD therapy - 1 year(s) ago
DENVER — In a Healio video exclusive, Alan Moss, MD, discusses his presentation at the Crohn’s and Colitis Congress, which detailed the use of therapeutic drug monitoring in the management of patients with inflammatory bowel disease. Speaking to attendees, Moss, director of the Crohn’s & Colitis program at Boston Medical Center, focused on three areas: the rationale and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a @GoHealio #GI #video exclusive, @moss_md discusses his presentation at #CCCongress23, which detailed the use of therapeutic drug monitoring in the management of #patients with #IBD. #GITwitter #MedTwitter https://t.co/ayf14sbWUe
-
-
Mashup Score: 0
Study finds no appetite for long-term adherence; lack of targeted education
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
"There is no one around to say 'No, you can't have that. It doesn't fit in your diet.'" -- @patelperseus, of @UCSF, on the difficulty of getting patients with #celiacdisease and #IBD to stick to a #glutenfree diet. https://t.co/bKUjlRIZjJ #GITwitter #CCCongress23
-
-
Mashup Score: 0‘Keep our hands on the wheel’: Caution, supervision urged as AI enters the IBD space - 1 year(s) ago
DENVER — Although the use of artificial intelligence for inflammatory bowel disease can reasonably replicate expert judgment and predict outcomes, clinicians must retain the ability to intervene and “take control” when the AI is wrong.“I don’t have to tell any of you that artificial intelligence is everywhere right now, doing some truly amazing tasks and starting to
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #CCCongress23: @CrohnsDoc said, ‘keep our hands on the wheel.' Urges #caution, #supervision as #AI enters the #IBD space #GITwitter #MedTwitter https://t.co/qOQpkz2QaM
-
-
Mashup Score: 0Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis - 1 year(s) ago
Falloon said IBD-associated peripheral arthritis is common, but not well understood.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
If you missed last week's #CCCongress23, check out this interview with Dr. Katie Falloon on IBD-Associated peripheral arthritis. https://t.co/JCFKNehQk8
-
#ICYMI: “Based on our #study results, #IBD #patients with non-STEMI require closer monitoring, and there needs to be a focus on better treatment and preventing complications that may develop,” @NeethiDasu told @GoHealio #GI. #CCCongress23 #GITwitter https://t.co/PdldXWncZn